✦ LIBER ✦

A 24-week, randomized, double-blind, placebo-controlled study to evaluate the efficacy, safety, and tolerability of the rivastigmine patch in Japanese patients with Alzheimer's disease

✍ Scribed by Nakamura, Yu; Imai, Yukimichi; Shigeta, Masahiro; Graf, Ana; Shirahase, Toru; Kim, Hyosung; Fujii, Akifumi; Mori, Joji; Homma, Akira

Book ID: 122059306
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 54 KB
Volume: 7
Category: Article
ISSN: 1552-5260
DOI: 10.1016/j.jalz.2011.05.2257

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Oral curcumin for Alzheimer's disease: t

Oral curcumin for Alzheimer's disease: tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study

✍ Ringman, John M; Frautschy, Sally A; Teng, Edmond; Begum, Aynun N; Bardens, Jenn 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 320 KB

A multicentre, randomized, double-blind,

A multicentre, randomized, double-blind, placebo-controlled study to evaluate the efficacy, tolerability and safety of two doses of metrifonate in patients with mild-to-moderate Alzheimer's disease: the MALT study

✍ Bruno Dubois; Ian McKeith; Jean-Marc Orgogozo; Owen Collins; Didier Meulien 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB 👁 3 views

Background. Metrifonate is a long-lasting acetylcholinesterase inhibitor being developed for the symptomatic treatment of Alzheimer's disease (AD). Objectives. This study compared the ecacy, tolerability and safety of two doses of metrifonate in patients with mild-to-moderate AD, over a 26-week tre

Efficacy and safety of canagliflozin in

Efficacy and safety of canagliflozin in Japanese patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, 12-week study

✍ Inagaki, N.; Kondo, K.; Yoshinari, T.; Maruyama, N.; Susuta, Y.; Kuki, H. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 643 KB

Mo2083 A Randomized, Double-Blind, Place

Mo2083 A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 827 in Subjects With Moderate to Severe Crohn's Disease

✍ Stephan R. Targan; Brian G. Feagan; Severine Vermeire; Remo Panaccione; Gil Y. M 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 89 KB

A randomized, double-blind, multicenter,

A randomized, double-blind, multicenter, placebo-controlled phase III trial to evaluate the efficacy and safety of pregabalin in Japanese patients with fibromyalgia

✍ Hiroyoshi Ohta, Hiroshi Oka, Chie Usui, Masayuki Ohkura, Makoto Suzuki, Kusuki N 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 370 KB

A phase 2, double-blind, randomized, pla

A phase 2, double-blind, randomized, placebo-controlled, dose-escalation study to evaluate the efficacy, safety, and tolerability of naloxegol in patients with opioid-induced constipation

✍ Webster, Lynn; Dhar, Sunita; Eldon, Michael; Masuoka, Lorianne; Lappalainen, Jaa 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 320 KB